Flow Cytometric Evaluation of Proliferating Cell Nuclear Antigen Expression in Human Hematopoietic Malignancies

References

• Lenner P, Roos G, Johansson H, Lindh J, Dige U. Non-Hodgkin's lymphoma-multivariate analysis of prognostic factors including fraction of S-phase cells. Acta Oncol 1987; 26: 179–83
   PubMed Web of Science ®Google Scholar
• Silvestrini R, Costa A, Giradini R, et al. Prognostic implications of cell kinetics, histopathology and pathologic state in non-Hodgkin's lymphomas. Hematol Oncol 1989; 7: 411–22
   PubMed Web of Science ®Google Scholar
• Cowan R A, Harris M, Jones M, Crowther D. DNA content in high and intermediate grade non-Hodgkin's lymphomaprognostic significance and clinicopathological correlations. Br J Cancer 1989; 60: 904–10
   PubMed Web of Science ®Google Scholar
• Kvaløy S, Godal T, Marlon P F, Steen H, Brennhovd I O, Abrahamsen A F. Spontaneous (3H)-thymidme uptake in histological subgroups of human B-cell lymphomas. Scand J Haematol 1981; 26: 221–34
   PubMedGoogle Scholar
• Sebo T J, Roche P C, Witzig T E, Kurtin P J. Proliferative activity in non-Hodgkin's lymphomas—A comparison of the Bromodeoxyuridine labeling index with PCNA immunostaining and quantitative image analysis. Am J Clin Pathol 1993; 99: 668–72
   PubMedGoogle Scholar
• Åkerman M, Brandt L, Johnson A, Olsson H. Mitotic activity in non-Hodgkin's lymphoma Relation to the Kiel classification and to prognosis. Br J Cancer 1987; 55: 219–23
   PubMed Web of Science ®Google Scholar
• Hall P A, Richards M A, Gregory W M, D'Ardenne A J, Lister T A, Stansfeld A G. The prognostic value of Ki67 immuno-staining in non-Hodgkin's lymphoma. J Pathol 1988; 154: 223–35
   PubMed Web of Science ®Google Scholar
• Klemi J, Alanamen K, Jalkanen S, Joensuu H. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma. Br J Cancer 1992; 66: 739–43
   PubMed Web of Science ®Google Scholar
• Swerdlow S H, Westermann C D, Pelstring R J, Saboorian M H, Williams M E. Growth fraction in centrocytic and follicular centre cell lymphomas: Assessment in paraffin sections with a proliferating cell nuclear antigen antibody and morphometric correlates. Hum Pathol 1993; 24: 540–6
   PubMed Web of Science ®Google Scholar
• Korkolpoulou P, Oates J, Kittas C, Crocker J. myc p53, c- p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas. J Clin Pathol 1994; 47: 9–14
   PubMedGoogle Scholar
• Sabattini E, Gerdes J, Gherlinzoni F, et al. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. J Pathol 1993; 169: 397–403
   PubMed Web of Science ®Google Scholar
• Lindh J, Jonsson H, Lenner P, Roos G. ‘Aggressive’ low grade lymphocytic lymphomas can be identified by flow cytometric S-phase determinations. Hematol Oncol 1992; 10: 171–9
   PubMed Web of Science ®Google Scholar
• Macartney J C, Camplejohn R S. DNA flow cytometry of non-Hodgkin's lymphoma. Eur J Cancer 1990; 26: 635–7
   PubMed Web of Science ®Google Scholar
• Tan E, Ogata K, Takasaki Y. PCNA/Cyclin: A lupus antigen connected with DNA replication. J Rheumatol 1987; 14(Suppl 13)91–6
   PubMedGoogle Scholar
• Bravo R, Macdonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987; 105: 1549–54
   PubMed Web of Science ®Google Scholar
• Landberg G, Roos G. Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells. Cytometry 1992; 6: 230–40
   Google Scholar
• Landberg G, Roos G. Antibodies to proliferating cell nuclear antigen (PCNA) as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 1991; 51: 4570–4
   PubMed Web of Science ®Google Scholar
• Begg A C, McNa Jly N J, Shrieve D C, Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620–2
   PubMedGoogle Scholar
• Gerhard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld A G, van Unnick J AM. Classification of non-Hodgkin's lymphomas. Lancet 1974; 2: 406–8
   Google Scholar
• Benett J M, Catovsky D, Churchill W H, et al. Proposed revised criteria for the classification of acute myeloid leukemia A report of the French-American-British co-operative group. Ann Intern Med 1985; 103: 620–5
   PubMedGoogle Scholar
• Vindeløv L L, Christensen I J, Nissen N I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323–7
   PubMedGoogle Scholar
• Erlanson M, Lindh J, Zackrisson B, Landberg G, Roos G. Cell kinetic analysis of non-Hodgkin's lymphoma using in vivo iododeoxyuridine incorporation and flow cytometry. Hemat Oncol 1995; 13: 207–17
   PubMedGoogle Scholar
• Wilson G D, Camplejohn R S, Martindale C A, Brock A, Lande D P, Barnes D M. Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10. Eur J Cancer 1992; 28A: 2010–7
   PubMed Web of Science ®Google Scholar
• Roos G, Landberg G, Huff J, et al. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies using synthetic peptides. Lab Invest 1993; 62: 204–10
   Google Scholar
• Landberg G, Roos G. Expression of proliferating cell nuclear antigen (PCNA) and KI-67 antigen in human hematopoietic cells. Acta Oncol 1991; 30: 917–21
   PubMed Web of Science ®Google Scholar
• Steel G. Growth kinetics of tumours. Oxford University Press, London 1977; 26
   Google Scholar
• Motukura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta 1993; 1155: 63–78
   PubMedGoogle Scholar
• Ohtsubo M, Theodoras A, Schumacher J, Roberts J, Pagano M. Human cyclin E, a nuclear protein essential for the Gl-to-S phase transition. Mol Cell Biol 1995; 15: 2612–24
   PubMed Web of Science ®Google Scholar
• Almasan A, Linke S, Paulsson T, Huang L, Wahl G. Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer and Metastasis Reviews 1995; 14: 59–73
   PubMed Web of Science ®Google Scholar
• Kaufmann W. Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer and Metastasis Reviews 1995; 14: 31–41
   PubMed Web of Science ®Google Scholar
• Murnane J P, Painter R B. Complementation of the defects of DNA synthesis in irradiated and unirradiated ataxia-telangiectasia cell line. Proc Natl Acad Sci USA 1982; 79: 1960–3
   PubMed Web of Science ®Google Scholar